Evince Biosciences
Evince Biosciences offers AI-powered drug discovery that aims to reduce time and cost in identifying promising therapies. It uses the AVO platform to describe molecules through virtual biological simulations and guide lead optimization. The system applies machine learning to predict beneficial chemical changes and prioritize which molecules to synthesize. Its internal cancer immunotherapy program focuses on activating innate and adaptive immune responses to boost tumor clearance. This approach targets biopharma partners and research organizations seeking efficient discovery workflows and scalable therapeutic development.
Evince Biosciences
Evince Biosciences offers AI-powered drug discovery that aims to reduce time and cost in identifying promising therapies. It uses the AVO platform to describe molecules through virtual biological simulations and guide lead optimization. The system applies machine learning to predict beneficial chemical changes and prioritize which molecules to synthesize. Its internal cancer immunotherapy program focuses on activating innate and adaptive immune responses to boost tumor clearance. This approach targets biopharma partners and research organizations seeking efficient discovery workflows and scalable therapeutic development.